首页> 外文期刊>Pediatric Surgery International >Are stable postoperative biliary atresia patients really stable?
【24h】

Are stable postoperative biliary atresia patients really stable?

机译:稳定的术后胆道闭锁患者真的稳定吗?

获取原文
获取原文并翻译 | 示例
           

摘要

Transforming growth factor-beta 1 (TGF β-1) is an important mediator of liver-cell proliferation and replication that is implicated in hepatic fibrosis (HF). Hepatic stellate cells (HSC) are activated by TGF β-1 and are the main precursor cells involved in fibrogenesis. The correlation between serum TGF β-1, activated HSC in liver-biopsy specimens, and liver biochemistry was investigated to determine the value of TGF β-1 as an indicator of clinical status in postoperative biliary atresia (BA) patients. Thirty-two postoperative BA patients (mean age 11.2 ± 2.8 years) and 13 normal controls (mean age 10.3 ± 3.7 years) were studied. Based on average liver function test (LFT) results over a 3-month period immediately prior to this study, the BA patients were divided into group I (anicteric, normal LFT; n = 10); group II (anicteric, elevated liver transaminases; n = 12), and group III (jaundiced end-stage liver fibrosis awaiting liver transplantation; n = 10). Serum TGF β-1 was determined using ELISA. Liver-biopsy specimens were examined with antibody against TGF β-1 and α-smooth muscle actin (SMA) antibody for detection of activated HSC. Serum TGF β-1 was significantly higher in groups I (11.4 ± 3.7 ng/ml; P < 0.01) and II (23.3 ± 11.3 ng/ml; P < 0.001) than in group III (3.0 ± 1.5 ng/ml) and controls (4.5 ± 2.5 ng/ml) despite normal LFT in group I. The 3 subjects with the highest serum TGF β-1 in group II had bile lakes. Biopsies from groups I and II were strongly positive for TGF β-1 in hepatocytes and Kupffer cells and for activated HSC detected by SMA compared with group III and controls. Because serum TGF β-1 and activated HSC are only present during active fibrosis, we conclude that there is progressive fibrogenesis even in seemingly normal postoperative BA patients. In particular, bile lakes should be regarded as a key sign of progressive HF, the presence of which should be regarded with extreme caution. We suggest that serum TGF β-1 could be used as an accurate indicator of progressive fibrogenesis in postoperative BA patients.
机译:转化生长因子β1(TGFβ-1)是肝细胞增殖和复制的重要介质,与肝纤维化(HF)有关。肝星状细胞(HSC)被TGFβ-1激活,是参与纤维发生的主要前体细胞。研究血清TGFβ-1,肝活检标本中活化的HSC与肝生化之间的相关性,以确定TGFβ-1作为术后胆道闭锁(BA)患者临床状况指标的价值。研究人员对32例术后BA患者(平均年龄11.2±2.8岁)和13名正常对照(平均年龄10.3±3.7岁)进行了研究。根据紧接此研究前3个月的平均肝功能测试(LFT)结果,将BA患者分为I组(抗风湿性,正常LFT; n = 10)。第二组(抗逆转录酶,肝转氨酶升高; n = 12),第三组(等待肝移植的黄疸末期肝纤维化; n = 10)。使用ELISA测定血清TGFβ-1。用抗TGFβ-1抗体和α平滑肌肌动蛋白(SMA)抗体检查肝活检标本,以检测活化的HSC。 I组(11.4±3.7 ng / ml; P <0.01)和II组(23.3±11.3 ng / ml; P <0.001)的血清TGFβ-1显着高于III组(3.0±1.5 ng / ml)和尽管I组的LFT正常,但对照组(4.5±2.5 ng / ml)。II组的3名血清TGFβ-1最高的受试者有胆汁色淀。与第三组和对照组相比,第一和第二组的活检组织对肝细胞和库普弗细胞中的TGFβ-1以及SMA检测到的活化的HSC呈强阳性。因为血清TGFβ-1和活化的HSC仅在活动性纤维化期间存在,所以我们得出结论,即使在看似正常的术后BA患者中也存在进行性纤维化。特别是,胆汁湖应被视为进行性HF的关键标志,应谨慎对待其存在。我们建议血清TGFβ-1可以作为术后BA患者进行性纤维生成的准确指标。

著录项

  • 来源
    《Pediatric Surgery International》 |2001年第3期|104-107|共4页
  • 作者单位

    Department of Pediatric Surgery Juntendo University School of Medicine 2-1-1 Hongo Bunkyo-ku Tokyo 113-8421 Japan;

    Department of Pediatric Surgery Juntendo University School of Medicine 2-1-1 Hongo Bunkyo-ku Tokyo 113-8421 Japan;

    Department of Pediatric Surgery Juntendo University School of Medicine 2-1-1 Hongo Bunkyo-ku Tokyo 113-8421 Japan;

    Department of Pediatric Surgery Juntendo University School of Medicine 2-1-1 Hongo Bunkyo-ku Tokyo 113-8421 Japan;

    Department of Central Laboratories Juntendo University School of Medicine Tokyo Japan;

    Department of Central Laboratories Juntendo University School of Medicine Tokyo Japan;

    Department of Pediatric Surgery Juntendo University School of Medicine 2-1-1 Hongo Bunkyo-ku Tokyo 113-8421 Japan;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

    Keywords Biliary atresia; Transforming growth factor-beta 1; Prognosis; Hepatic stellate cells; α-Smooth muscle actin;

    机译:胆道闭锁;转化生长因子β1;预后;肝星状细胞;α-平滑肌肌动蛋白;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号